KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Guardant Health (GH) EBIT Margin (2017 - 2025)

Historic EBIT Margin for Guardant Health (GH) over the last 9 years, with Q3 2025 value amounting to 37.33%.

  • Guardant Health's EBIT Margin rose 239500.0% to 37.33% in Q3 2025 from the same period last year, while for Sep 2025 it was 49.02%, marking a year-over-year increase of 254000.0%. This contributed to the annual value of 60.02% for FY2024, which is 401100.0% up from last year.
  • According to the latest figures from Q3 2025, Guardant Health's EBIT Margin is 37.33%, which was up 239500.0% from 45.85% recorded in Q2 2025.
  • In the past 5 years, Guardant Health's EBIT Margin registered a high of 37.33% during Q3 2025, and its lowest value of 137.12% during Q1 2021.
  • Over the past 5 years, Guardant Health's median EBIT Margin value was 90.84% (recorded in 2021), while the average stood at 89.93%.
  • Per our database at Business Quant, Guardant Health's EBIT Margin crashed by -854000bps in 2021 and then skyrocketed by 649700bps in 2024.
  • Quarter analysis of 5 years shows Guardant Health's EBIT Margin stood at 90.84% in 2021, then fell by -27bps to 115.15% in 2022, then fell by -11bps to 127.38% in 2023, then surged by 51bps to 62.42% in 2024, then surged by 40bps to 37.33% in 2025.
  • Its EBIT Margin was 37.33% in Q3 2025, compared to 45.85% in Q2 2025 and 54.57% in Q1 2025.